Twist Bioscience Overview
- Founded
- 2013

- Status
- Public
- Employees
- 652

- Stock Symbol
- TWST

- Investments
- 4
- Share Price
- $34.94
- (As of Tuesday Closing)
Twist Bioscience General Information
Description
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Contact Information
- 681 Gateway Boulevard
- South San Francisco, CA 94080
- United States
Twist Bioscience Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$34.94 | $37.42 | $25.88 - $139.99 | $2.11B | 56.3M | 975K | -$3.72 |
Twist Bioscience Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 30-Sep-2021 | FY 2020 30-Sep-2020 | FY 2019 30-Sep-2019 |
---|---|---|---|---|
EV | 2,541,937 | 4,817,120 | 3,119,206 | 624,171 |
Revenue | 163,114 | 132,333 | 90,100 | 54,385 |
EBITDA | (188,156) | (144,346) | (133,584) | (103,004) |
Net Income | (187,510) | (152,098) | (139,931) | (107,669) |
Total Assets | 1,021,636 | 702,097 | 398,882 | 186,994 |
Total Debt | 79,662 | 62,921 | 35,982 | 7,733 |
Twist Bioscience Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Twist Bioscience‘s full profile, request access.
Request a free trialTwist Bioscience Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
This information is available in the PitchBook Platform. To explore Twist Bioscience‘s full profile, request access.
Request a free trialTwist Bioscience Comparisons
Industry
00000 00
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialTwist Bioscience Competitors (24)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Codex DNA | Formerly VC-backed | San Diego, CA | 000 | 00000 | 00000000 | 00000 |
0000000000 | Formerly VC-backed | Menlo Park, CA | 000 | 00000 | 00000000 | 00000 |
000000000 00000000 | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 00000000000 | 000.00 |
0000000 | Venture Capital-Backed | Cambridge, United Kingdom | 00 | 000.00 | 00000000000 | 000.00 |
00000000 | Formerly VC-backed | San Diego, CA | 00000 | 00000 | 000000&0 |
Twist Bioscience Patents
Twist Bioscience Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210355194-A1 | Variant nucleic acid libraries for coronavirus | Pending | 27-Apr-2020 | 000000000 | |
US-20210179724-A1 | Variant nucleic acid libraries for adenosine receptors | Pending | 09-Dec-2019 | 000000000 | |
US-20210102192-A1 | Variant nucleic acid libraries for crth2 | Pending | 23-Sep-2019 | 000000000 | |
US-20210102195-A1 | Variant nucleic acid libraries for single domain antibodies | Pending | 23-Sep-2019 | 00000000000 | |
US-20210071168-A1 | Barcode-based nucleic acid sequence assembly | Pending | 21-Jun-2019 | C12N9/1241 |
Twist Bioscience Executive Team (19)
Twist Bioscience Board Members (19)
Name | Representing | Role | Since |
---|---|---|---|
Emily Leproust Ph.D | Twist Bioscience | Chief Executive Officer & Chairman | 000 0000 |
Frederick Craves Ph.D | Self | Board Member | 000 0000 |
Jan Johannessen | Twist Bioscience | Board Member | 000 0000 |
Keith Crandell | ARCH Venture Partners | Board Member | 000 0000 |
Melissa Starovasnik | Twist Bioscience | Board Member | 000 0000 |
Twist Bioscience Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTwist Bioscience Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Twist Bioscience‘s full profile, request access.
Request a free trialTwist Bioscience Investments & Acquisitions (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 | 01-Dec-2021 | 0000000000 | 00000 | Drug Discovery | 00000 000 |
0000000 00000 | 01-Nov-2021 | 000000000 | 000.00 | Biotechnology | 00000 000 |
0000000 | 14-Jun-2021 | 0000000000 | 000.00 | Other Healthcare Technology Systems | 00000 000 |
Genome Compiler | 07-Apr-2016 | Merger/Acquisition | 00.00 | Biotechnology | 00000 000 |
Twist Bioscience Subsidiaries (3)
Company Name | Industry | Location | Founded |
---|---|---|---|
Abveris | Drug Discovery | Quincy, MA | 2017 |
0000000 | Other Healthcare Technology Systems | San Francisco, CA | 0000 |
000000 00000000 | Biotechnology | Los Altos, CA | 0000 |